News

Over 350 researchers, students and guests attended the 20th UK Cardiovascular Research Day at the Lexington Convention Center, an annual event that celebrates the innovative research in cardiovascular health.

The Hillman Innovations in Care Program grant will be used to expand access to the PATHways program in communities who may not have the resources available to provide this type of multidisciplinary care to mothers with perinatal opioid use disorder.

The 2018 National Conference on Undergraduate Research is scheduled April 4-7, 2018. However, the deadline for submissions is Dec. 5.

Nearly 15% of Kentucky children are currently diagnosed with ADHD, the highest rate in the nation. While medicine alone doesn't necessarily lead to improved academic performance in the long run, a new intervention developed by UK professors is aiming to do just that.

The American Heart Association awarded its Population Research Prize for 2017 to Donna K. Arnett, dean of the UK College of Public Health and professor of epidemiology.

In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.

Three professors in the University of Kentucky College of Communication and Information have been recognized for their scholarly productivity in communication studies.

A new program between the University of Kentucky Center for Clinical and Translational Science and the Indiana Clinical and Translational Science Institute aims to share research expertise between the two institutions.

The Kentucky Injury Prevention and Research Center at the UK College of Public Health, in collaboration with the Kentucky Office of the State Medical Examiner's Office and county coroner offices, recently published the inaugural Kentucky Drug Overdose Fatality Surveillance System report.

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.